160 related articles for article (PubMed ID: 3421563)
1. Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
Fig LM; Gross MD; Shapiro B; Ehrmann DA; Freitas JE; Schteingart DE; Glazer GM; Francis IR
Ann Intern Med; 1988 Oct; 109(7):547-53. PubMed ID: 3421563
[TBL] [Abstract][Full Text] [Related]
2. Adrenal scintigraphy with 131I-19-iodochlesterol in the diagnosis of Cushing's syndrome associated with adrenal tumor.
Barliev GB
Eur J Nucl Med; 1979 Dec; 4(6):449-51. PubMed ID: 520360
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing benign from malignant euadrenal masses.
Gross MD; Shapiro B; Bouffard JA; Glazer GM; Francis IR; Wilton GP; Khafagi F; Sonda LP
Ann Intern Med; 1988 Oct; 109(8):613-8. PubMed ID: 3421574
[TBL] [Abstract][Full Text] [Related]
4. Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy.
Gross MD; Shapiro B; Freitas JE
J Nucl Med; 1985 Jan; 26(1):43-8. PubMed ID: 2981301
[TBL] [Abstract][Full Text] [Related]
5. Adrenal scintigraphy in Cushing's syndrome caused by bilateral hyperplasia, adenoma or carcinoma.
Lindberg S; Ernest I; Fjälling M; Holmdahl C
Nucl Med Commun; 1985 Jan; 6(1):31-6. PubMed ID: 3039430
[TBL] [Abstract][Full Text] [Related]
6. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
[TBL] [Abstract][Full Text] [Related]
7. [Nuclear medicine diagnostic localization in primary aldosteronism and Cushing syndrome].
Sialer G; Marincek B; Mengden T; Vetter W
Bildgebung; 1987-1989; 56(4):157-62. PubMed ID: 3078253
[TBL] [Abstract][Full Text] [Related]
8. Computed tomographic scanning versus radioisotope imaging in adrenocortical diagnosis.
Guerin CK; Wahner HW; Gorman CA; Carpenter PC; Sheedy PF
Am J Med; 1983 Oct; 75(4):653-7. PubMed ID: 6624772
[TBL] [Abstract][Full Text] [Related]
9. [Cushing with transition from pituitary to adrenal origin. Study with SPECT scintigraphy of the adrenal cortex with norcholesterol-I 131 in a case].
Araya V; Jofré J; Hidalgo P; Massardo T; Amat J; Pumarino H
Rev Med Chil; 1998 Sep; 126(9):1103-7. PubMed ID: 9922515
[TBL] [Abstract][Full Text] [Related]
10. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
Taillefer R; Soucy JP; Eybalin MC; Levasseur A
J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
[TBL] [Abstract][Full Text] [Related]
11. Radiocholesterol scintigraphy in Cushing's syndrome.
Rufini V; Saletnich I; Troncone L
Rays; 1992; 17(1):40-8. PubMed ID: 1636017
[No Abstract] [Full Text] [Related]
12. Adrenal cortical adenoma causing Cushing's syndrome: correct localization by functional scintigraphy despite nonlocalizing morphological imaging studies.
Geatti O; Fig L; Shapiro B
Clin Nucl Med; 1990 Mar; 15(3):168-71. PubMed ID: 2317996
[TBL] [Abstract][Full Text] [Related]
13. [Nuclear medicine methods for the diagnosis of adrenal tumors].
Gregianin M; Bui F; Varotto L; Zucchetta P; Macri C
Minerva Endocrinol; 1995 Mar; 20(1):27-38. PubMed ID: 7651280
[TBL] [Abstract][Full Text] [Related]
14. [Dissociation between absorption of 131I-19-iodocholesterol and hormonal activity in corticosteroma patients].
Burliev G; Koev D; Zlatareva N; Khubaveshki S
Vutr Boles; 1987; 26(3):88-91. PubMed ID: 3617712
[TBL] [Abstract][Full Text] [Related]
15. [ACTH-independent bilateral macronodular adrenocortical hyperplasia (AIMAH): a case report].
Miki T; Nakayama J; Shimizu K; Hosomi M; Kiyohara H; Takeda M; Hanada M
Hinyokika Kiyo; 1999 Apr; 45(4):245-8. PubMed ID: 10363143
[TBL] [Abstract][Full Text] [Related]
16. Radioisotopic study of the adrenal glands using 131I-19-iodocholesterol.
Troncone L; Galli G; Salvo D; Barbarino A; Bonomo L
Br J Radiol; 1977 May; 50(593):340-9. PubMed ID: 861453
[TBL] [Abstract][Full Text] [Related]
17. [ACTH-independent macronodular adrenal hyperplasia and subclinical Cushing's syndrome].
Cortés-Berdonces M; Avilés-Pérez MD; García-Martín A; Muñoz-Torres M
Med Clin (Barc); 2012 Feb; 138(2):89-90. PubMed ID: 21703642
[No Abstract] [Full Text] [Related]
18. The diagnosis of Cushing's syndrome using 131I-19-iodocholesterol uptake and adrenal imaging.
Ortega D; Foz M; Doménech-Torné FM; Tresánchez JM
Clin Endocrinol (Oxf); 1980 Aug; 13(2):145-9. PubMed ID: 7438469
[TBL] [Abstract][Full Text] [Related]
19. Cushing's syndrome due to unilateral adrenocortical hyperplasia.
Otsuka F; Ogura T; Nakao K; Hayakawa N; Mimura Y; Yamauchi T; Makino H
Intern Med; 1998 Apr; 37(4):385-90. PubMed ID: 9630199
[TBL] [Abstract][Full Text] [Related]
20. Adrenal scintigraphy in the morphological and functional evaluation of Cushing's syndrome.
Bui F; Macri' C; Varotto L; Boscaro M; Mantero F
Cardiology; 1985; 72 Suppl 1():76-83. PubMed ID: 2996768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
